期刊文献+

IFN-γ增强人γδT细胞杀伤骨肉瘤细胞的研究 被引量:13

Interferon-γ enhances human γδ T cell-mediated osteosarcoma cell killing in vitro
下载PDF
导出
摘要 目的研究干扰素-γ(IFN-γ)增强骨肉瘤患者γδT细胞对骨肉瘤杀伤作用的影响。方法以唑来磷酸法扩增骨肉瘤患者外周血γδT细胞。分别使用实时荧光定量聚合酶链反应和流式细胞术检测IFN-γ处理前后骨肉瘤细胞Fas的表达情况;LDH法检测骨肉瘤患者γδT细胞对骨肉瘤细胞的杀伤活性。结果 IFN-γ对骨肉瘤细胞Fas的表达明显提高(P<0.01),骨肉瘤患者γδT细胞对骨肉瘤细胞的杀伤作用显著增强(P<0.01)。抗人FasL抗体对γδT细胞杀伤OS细胞作用影响较小(P>0.05);但能显著阻断γδT细胞杀伤IFN-γ预处理OS细胞的作用,差异均有统计学意义(P<0.01)。结论 IFN-γ可增强骨肉瘤患者γδT细胞的抗骨肉瘤作用。 Objective To investigate the cytotoxic effect of γδ T cells from osteosarcoma patients against interferon-γ(IFN-γ)-treated osteosarcoma cells in vitro. Methods Human γδ T cells were amplified by zoledronate from peripheral blood cells of osteosarcoma patients. The expression of Fas on the osteosarcoma cells were measured by flow cytometry and quantitative real-time PCR analysis before and after IFN-γ treatment. The cytoxicity ofγδ T cells against osteosarcoma cells was evaluated with LDH assay. Results IFN-γ significantly enhanced the susceptibility of the osteosarcoma cell lines HOS and U2OS to the cycotoxicity of γδ T cells from osteosarcoma patients (P〈0.01). IFN-γ obviously up-regulated the expression of Fas in HOS and U2OS cells (P〈0.01). Anti-FasL mAb failed to inhibit the cytotoit icity of γδ T ceils in untreated osteosarcoma targets (P〉0.05), but significantly impaired γδT cell cytotoxicity in IFN-γ pre-treated osteosarcoma targets (P〈0.01). Conclusion IFN-y can enhance the cytotoxic effect of human γδ T cells from osteosarcorna patients against osteosarcoma cells in vitro
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第1期22-25,共4页 Journal of Southern Medical University
基金 国家自然科学基金(81172547)~~
关键词 免疫治疗 骨肉瘤 干扰素Γ ΓΔT细胞 immunotherapy osteosarcoma interferon-y γδ T cells
  • 相关文献

参考文献14

  • 1徐强,李朝旭,叶招明.氯化两面针碱对人骨肉瘤细胞的诱导凋亡作用及其机制[J].南方医科大学学报,2011,31(2):361-364. 被引量:14
  • 2Sakamoto A, Iwamoto Y. Current status and perspectives regardingthe treatment of osteo-sarcoma: chcmotherapy[J]. Rev Recent ClinTrials, 2008, 3(3):228-31.
  • 3苏海涛,黄永明,许少健,石宇雄,徐逸生,刘金文.加味六味地黄汤对骨肉瘤化疗患者免疫功能的影响[J].南方医科大学学报,2010,30(6):1412-1414. 被引量:6
  • 4Muraro M, Mereuta OM, Carraro F, ct al. Ostcosarcoma cell linegrowth inhibition by zoledronate-stimulatcd effector cells [j]. CellImmunol, 2007,249(2): 63-72.
  • 5Capietto AH, Martinet L, Foumic JJ. How tumors might withstandgammadclta T-cell attack [J].Cell Mol Life Sci, 2011. 68(14):2433-42.
  • 6Glibetiv M, Buck S, et al. Interteron-gamma sensitizesostcosarcoma cells to Fas-induced apoptosis by up-regulating Fasrcccptors and caspase-8 [J]. Pediatr Blood Canccr, 2004, 43(7):729-36.
  • 7Li Z, Xu Q, Peng H, et al. IFN-gamma enhances HOS and U20Scell lines susceptibility to gammadclta T cell-mediated killingthrough the Fas/Fas ligand pathway [J]. Int Iinmunopharniacol,2011,11(4):496-503.
  • 8蒋晖,徐强,杨超,曹贞国,李朝旭,叶招明.γδT细胞经唑来膦酸刺激后对骨肉瘤细胞的杀伤作用[J].细胞与分子免疫学杂志,2010,26(12):1195-1197. 被引量:8
  • 9李朝旭,孙凌凌,程瑞林,孙正旺,叶招明.唑来膦酸刺激健康人和骨肉瘤PBMCs体外扩增γδT细胞[J].细胞与分子免疫学杂志,2012,28(8):822-824. 被引量:8
  • 10Li Z,Peng H, Xu Q, ct al. Sensitization of human ostcosarcomacells to Vgamma9Vdclta2 T-cell-mediated cytotoxicity byzolcdronatej J]. J Orthop Res, 2012, 30(5): 824-30.

二级参考文献36

  • 1焦红军.党参的药理作用及其临床应用[J].临床医学,2005,25(4):92-92. 被引量:171
  • 2秦三海,刘华钢,王博龙,杨斌.氯化两面针碱体外诱导肺癌SPC-A-1、舌癌Tca8113两种肿瘤细胞株凋亡的研究[J].中国药理学通报,2007,23(2):279-280. 被引量:27
  • 3Laurent C, Sa Cunha A, Couderc P, et al. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases[J]. Br J Surg, 2003, 90(9): 1131-6.
  • 4Bubenik J.Tumour MHC class Ⅰ downregulation and immunotherapy[J].Oncol Rep,2003,10(6):2005-2008.
  • 5Mariani S,Muraro M,Pantaleoni F,et al.Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma[J].Leukemia,2005,19(4):664-670.
  • 6Lozupone F,Pende D,Burgio VL,et al.Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice[J].Cancer Res,2004,64(1):378-385.
  • 7Takeshi Y,Kiyoshi S,Eishi A,et al.Intravesical administration of γδT cells successfully prevents the growth of bladder cancer in the murine model[J].Cancer Immunol Immunother,2009,58(4):493-502.
  • 8Franeoise B,Florian C,Olivier T,et al.Vγ9Vδ2 T cell-mediated recognition of human solid tumors.Potential for immunotherapy of hepatocellular and colorectal carcinomas[J].Cancer Immunol Immunother,2008,57(4):531-539.
  • 9Bacei G,Brieeoli A,Ferrari S,et al.Neoadjuvant chemotherapy for osteosarcoma of the extremity.Long-term results of the Rizzoli's 4th protocol[J].Eur J Cancer,2001,37(16):2030-2039.
  • 10Fagioli F, Biasin E, Mereuta OM, et al. Poor prognosis osteosarcoma: new therapeutic approach [J].Bone Marrow Transplant, 2008, 41(Suppl 2): S131-4.

共引文献30

同被引文献121

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部